FDA Approved: LAMOTRIGINE — Supplemental Application (Yiling Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved Yiling Pharmaceutical's supplemental application to market Lamotrigine Extended-Release, a lamotrigine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine Extended-Release (Lamotrigine extended-release)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE EXTENDED-RELEASE)